Rapid non-invasive ploidy detection for wheat DH breeding using NIR spectroscopy
Innovative non-destructive method employing NIR spectroscopy for early detection of doubled haploid wheat embryos, enhancing breeding efficiency and cost-effectiveness without regulatory hurdles.
Overview
This breakthrough technology leverages Near-Infrared (NIR) spectroscopy combined with advanced chemometric modeling to identify doubled haploid (DH) wheat embryos non-invasively. By targeting biochemical signatures within the intact embryo, this method facilitates early detection, surpassing traditional leaf-based approaches and preserving embryo viability. The system supports high-throughput screening with binary output, seamlessly integrating into existing breeding LIMS, and eliminating the need for DNA extraction or tissue sampling. This solution enables significant operational cost reductions and accelerates breeding cycles, aligning with breeding KPIs and regulatory compliance.
Technical specifications
- Utilizes NIR spectroscopy for non-destructive analysis of wheat embryo biochemical markers.
- Advanced chemometric modeling optimizes spectral regions and preprocessing to isolate ploidy-specific signals.
- High sensitivity (>95%) ensures minimal risk of discarding fertile lines.
- System integrates with breeding LIMS for streamlined workflow.
- No DNA extraction or tissue sampling required, ensuring regulatory compliance.
- Economically advantageous by eliminating costs associated with maintaining sterile material pre-germination.
Technology readiness level
Currently at Technology Readiness Level 2, the solution has undergone an independent review and a phased validation plan is in place. The plan includes feasibility studies, model development, laboratory validation, and operational validation, ensuring robustness across diverse genotypes.
About Consulting-ai
Consulting-ai operates as a consultancy providing customized artificial intelligence solutions designed to transform enterprise operations. The company claims to develop proprietary technology integrated with scientific databases—including TOXNET, PubChem, DrugBank, and MatWeb—to deliver specialized results. Their approach utilizes adaptive deep learning models with specific fine-tuning and federated learning techniques that employ homomorphic encryption to maintain data privacy and regulatory compliance, such as GDPR, HIPAA, and REACH.
These services are aimed at helping organizations across various industries reduce operational costs, optimize processes, and improve the precision of their workflows. By emphasizing the use of proprietary data and tailored implementations, the firm positions its offerings as distinct from generic commercial AI models, intending to provide scalable, high-performance solutions for complex, heterogeneous data environments.
delivered to your inbox.